Dokumendiregister | Terviseamet |
Viit | 10.2-7/25/1389-1 |
Registreeritud | 21.02.2025 |
Sünkroonitud | 24.02.2025 |
Liik | Sissetulev dokument |
Funktsioon | 10.2 Toodete terviseohutusega seotud toimingud |
Sari | 10.2-7 Tubakatooted |
Toimik | 10.2-7/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Dirc Group |
Saabumis/saatmisviis | Dirc Group |
Vastutaja | Jaana Tammiku-Taul (TA, Peadirektori asetäitja (1) vastutusvaldkond, Kemikaaliohutuse osakond) |
Originaal | Ava uues aknas |
Dear Estonian Health Board (Terviseamet),
I am emailing to understand the submission process for a study we are looking to conduct in your country. This research study does not have an investigational medicinal product (IMP) or medical device. The investigated product is a consumer device with tobacco product. The study is evaluating cigarettes against this tobacco heating system in patients with COPD.
Can I confirm if this type of study would require submission to you? If yes, please can you provide details on how this type of submission would occur?
Many thanks for your input and support
Best wishes,
Rachael
Rachael Perrio
Senior Regulatory Executive
Upcoming Leave: 28th February
Tel: +44 (0)1462 372472
Mobile: +44 (0)7563 028913
The information transmitted in this message is intended only for the person or entity it is addressed to and may contain confidential and/or privileged material. Any review, retransmission, dissemination or otherwise of, or taking of any action in reliance upon, this information by person or persons or entities other than the intended recipient is prohibited. If you receive it in error, please contact the sender and delete the material from any computer. Global Offices: UK | Germany | US. Company Information & Legal Notices.
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.